Please Wait
Applying Filters...
menu
    • menu

    Annual Sales of Argipressin Tannate reported using PharmaCompass' compilation of Annual Reports of Global Pharmaceutical Companies.

    Client Email Product
    Renejix: CDMO with expertise in small molecule oral dosage, delivery tech, and multi-modality manufacturing.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Ribobay has expertise in oligonucleotides from siRNA, Antisense Oligonucleotides, miRNAs, and aptamers & Oligonucleotides CXOs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Argipressin Tannate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 2,763,600Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 6Vasostrict

    PharmaCompass
    Left Arrow
    Right Arrow
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Vasostrict

    Vasopressin

    arrow
    34th IFSCC
    Not Confirmed

    Brand Name : Vasostrict

    Ireland
    arrow
    34th IFSCC
    Not Confirmed

    Endo Pharma

    Vasopressin

    Main Therapeutic Indication : Nephrology

    Currency : USD

    2020 Revenue in Millions : 786

    2019 Revenue in Millions : 532

    Growth (%) : 48

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Vasostrict

    Vasopressin

    arrow
    34th IFSCC
    Not Confirmed

    Brand Name : Vasostrict

    Ireland
    arrow
    34th IFSCC
    Not Confirmed

    Endo Pharma

    Vasopressin

    Main Therapeutic Indication : Nephrology

    Currency : USD

    2021 Revenue in Millions : 902

    2020 Revenue in Millions : 786

    Growth (%) : 15

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Vasostrict

    Vasopressin

    arrow
    34th IFSCC
    Not Confirmed

    Brand Name : Vasostrict

    Ireland
    arrow
    34th IFSCC
    Not Confirmed

    Endo Pharma

    Vasopressin

    Main Therapeutic Indication : Cardiology/Vascular Diseases

    Currency : USD

    2022 Revenue in Millions : 254

    2021 Revenue in Millions : 902

    Growth (%) : -72

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Brand Name : Vasostrict

    Vasopressin

    arrow
    34th IFSCC
    Not Confirmed

    Brand Name : Vasostrict

    Ireland
    arrow
    34th IFSCC
    Not Confirmed

    Endo Pharma

    Vasopressin

    Main Therapeutic Indication : Cardiology/Vascular Diseases

    Currency : USD

    2023 Revenue in Millions : 93

    2022 Revenue in Millions : 254

    Growth (%) : -63

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Brand Name : Vasostrict

    Arginine Vasopressin

    arrow
    34th IFSCC
    Not Confirmed

    Brand Name : Vasostrict

    Ireland
    arrow
    34th IFSCC
    Not Confirmed

    Endo Pharmaceuticals

    Arginine Vasopressin

    Main Therapeutic Indication : Renal Disorders

    Currency : USD

    2018 Revenue in Millions : 454

    2017 Revenue in Millions : 400

    Growth (%) : 14%

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Brand Name : Vasostrict

    Vasopressin

    arrow
    34th IFSCC
    Not Confirmed

    Brand Name : Vasostrict

    Ireland
    arrow
    34th IFSCC
    Not Confirmed

    Endo Pharma

    Vasopressin

    Main Therapeutic Indication : Nephrology

    Currency : USD

    2019 Revenue in Millions : 532

    2018 Revenue in Millions : 454

    Growth (%) : 17

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF